1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
PlyKp104, a Novel Phage Lysin for the Treatment of Klebsiella pneumoniae, Pseudomonas aeruginosa, and Other Gram-Negative ESKAPE Pathogens
(
- Contribution to journal › Article
- 2017
-
Mark
Determining bacteriophage endopeptidase activity using either fluorophore-quencher labeled peptides combined with liquid chromatography-mass spectrometry (LC-MS) or Förster resonance energy transfer (FRET) assays
(
- Contribution to journal › Article
- 2016
-
Mark
Novel engineered peptides of a phage lysin as effective antimicrobials against multidrug-resistant Acinetobacter baumannii
(
- Contribution to journal › Article
- 2015
-
Mark
Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model
(
- Contribution to journal › Article
- 2014
-
Mark
Activity assays for bacteriophage endolysin PlyPy
(
- Contribution to journal › Article
-
Mark
A highly active and negatively charged Streptococcus pyogenes lysin with a rare D-alanyl-L-alanine endopeptidase activity protects mice against streptococcal bacteremia
(
- Contribution to journal › Article
- 2010
-
Mark
Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus
(
- Contribution to journal › Article
- 2008
-
Mark
Rapid DNA library construction for functional genomic and metagenomic screening
(
- Contribution to journal › Article
- 2004
-
Mark
A Novel secreted endoglycosidase from Enterococcus faecalis with activity on human immunoglobulin G and ribonuclease B
(
- Contribution to journal › Article